Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Takeuchi

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Cancer Medicine|November 11, 2017
In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugsKenji Kita, Sachiko Arai, Akihiro Nishiyama, et al.
Anticancer Research|October 2, 2019
Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary DiseasesKoushiro Ohtsubo, Kunio Miyake, Sachiko Arai, et al.
Cancer Science|April 1, 2022
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cellsChiaki Suzuki, Akihiro Nishiyama, Sachiko Arai, et al.
Journal of Biomedical Science|July 11, 2024
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damageHiroshi Kotani, Hiroko Oshima, Justin C Boucher, et al.
Cancer Science|August 22, 2019
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistanceKenji Kita, Koji Fukuda, Hiro Takahashi, et al.
Experimental Hematology & Oncology|September 28, 2024
Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancersHiroshi Kotani, Tomoyoshi Yamano, Justin C Boucher, et al.
Molecular Cancer Therapeutics|May 10, 2011
E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptorHirokazu Ogino, Masaki Hanibuchi, Soji Kakiuchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 11, 2014
Lack of association between the BIM deletion polymorphism and the risk of lung cancer with and without EGFR mutationsHiromichi Ebi, Isao Oze, Takayuki Nakagawa, et al.
The Journal of Cell Biology|June 6, 2023
Ultrafast single-molecule imaging reveals focal adhesion nano-architecture and molecular dynamicsTakahiro K Fujiwara, Taka A Tsunoyama, Shinji Takeuchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2025
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung CancerKoji Fukuda, Shigeki Nanjo, Shinji Takeuchi, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Cancer Medicine|November 11, 2017
In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugsKenji Kita, Sachiko Arai, Akihiro Nishiyama, et al.
Anticancer Research|October 2, 2019
Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary DiseasesKoushiro Ohtsubo, Kunio Miyake, Sachiko Arai, et al.
Cancer Science|April 1, 2022
Inhibition of EGFR and MEK surmounts entrectinib resistance in a brain metastasis model of NTRK1-rearranged tumor cellsChiaki Suzuki, Akihiro Nishiyama, Sachiko Arai, et al.
Journal of Biomedical Science|July 11, 2024
Dual inhibition of SUMOylation and MEK conquers MYC-expressing KRAS-mutant cancers by accumulating DNA damageHiroshi Kotani, Hiroko Oshima, Justin C Boucher, et al.
Cancer Science|August 22, 2019
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistanceKenji Kita, Koji Fukuda, Hiro Takahashi, et al.
Experimental Hematology & Oncology|September 28, 2024
Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancersHiroshi Kotani, Tomoyoshi Yamano, Justin C Boucher, et al.
Molecular Cancer Therapeutics|May 10, 2011
E7080 suppresses hematogenous multiple organ metastases of lung cancer cells with nonmutated epidermal growth factor receptorHirokazu Ogino, Masaki Hanibuchi, Soji Kakiuchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 11, 2014
Lack of association between the BIM deletion polymorphism and the risk of lung cancer with and without EGFR mutationsHiromichi Ebi, Isao Oze, Takayuki Nakagawa, et al.
The Journal of Cell Biology|June 6, 2023
Ultrafast single-molecule imaging reveals focal adhesion nano-architecture and molecular dynamicsTakahiro K Fujiwara, Taka A Tsunoyama, Shinji Takeuchi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 15, 2025
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung CancerKoji Fukuda, Shigeki Nanjo, Shinji Takeuchi, et al.
Pageof 12